Pharvaris (PHVS) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The EV/EBITDA trajectory of Pharvaris N.V. (PHVS) helps isolate market noise from actual efficiency. The 0.00 indicator determines the magnitude of the metric. The business dominates the tablet-based rare edema treatment segment, displacing injections through its patents. AI is accelerating formula discovery, although physicians maintain control over testing. Stable management preserves shareholder confidence by successfully overcoming regulatory barriers.
pharvaris.com - analytical breakdowns and key metrics (PHVS)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
PHVS - Net Profit|Expected Profit Pharvaris N.V.|PHVS - Company Value to Net Income|Projected Price to Earnings Pharvaris N.V.|PHVS - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Pharvaris Pharma|PHVS - Operating profit EBITDA|Earnings per share for the last twelve months Pharvaris|PHVS - Earnings per share for the trailing year|Quarterly EPS earnings growth pharvaris.com|PHVS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Pharvaris N.V.
Initial company analysis:PHVS (Pharvaris Corp)
The EV/EBITDA metric determines the total enterprise value, including debt, relative to operating income before interest and taxes, reflecting the payback period of assets. By analyzing the EV/EBITDA ratio of Pharvaris N.V. (PHVS) across a financial timeline, an investor assesses the company's resilience to the cost of capital, as valuations in the R&D sector are driven by the efficiency of new drug development rather than economic cycles.
Direct competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio DNTH|ABCL: EV/EBITDA Multiple|tourmalinebio.com - Business Value to Operating Income Before Depreciation|PGEN (Precigen) - EV/EBITDA Multiple|EV/EBITDA Multiple Pharming Group NV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nektar (NKTR)|UPB (Upstream Pharma) - Business Value to Operating Income Before Depreciation|Zenas Biopharma Inc - Enterprise Value to EBITDA Ratio|immunome.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Gossamer Bio - EV/EBITDA Multiple|KALV - EV/EBITDA Multiple|Septerna Corp (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Pieris Corp - Business Value to Operating Income Before Depreciation|SVRA (Savara Inc.) - EV/EBITDA Multiple|rigel.com (RIGL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio (ANAB)|Total Company Value to Operating Income Before Depreciation Ratio Astria Therapeutics Inc|enGene Bio - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation RAPT|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACRS (aclaristx.com) - Enterprise Value to Operating Income Before Depreciation|KYTX (Kyverna Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio CABA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VTYX|Enterprise Value to EBITDA Ratio THTX (Theratechnologies Inc.)|Total Company Value to Operating Income Before Depreciation Ratio avalotx.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Company Value to Operating Income Before Depreciation Ratio|Climb Bio, Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation ZURA (zurabio.com)|ATYR (aTyr Pharma, Inc.) - Enterprise Value to EBITDA Ratio|ADAG (Adagene Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|Shattuck Therapeutics (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple IMUX (Immunic)|Business Value to Operating Income Before Depreciation ATRA|InflaRx GmbH - EV/EBITDA Multiple|XFOR - EV/EBITDA Multiple|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Celularity - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to EBITDA Ratio barinthusbio.com (BRNS)|EV/EBITDA Multiple KZR|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|Akari Therapeutics plc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENLV|Q32 Bio Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio geovax.com GOVX|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to EBITDA Ratio BOLT (Bolt Biotherapeutics)|EV/EBITDA Multiple hcwbiologics.com (HCWB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM: Enterprise Value to Operating Income Before Depreciation|Aditxt Corp - EV/EBITDA Multiple|Company Value to EBITDA GRI Bio Corporation|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio HIND (reshapelifesciences.com)|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|INDP: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SCNI|EV/EBITDA Multiple calcimedica.com (CALI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|Business Value to Operating Income Before Depreciation ALLK|HOOK: Enterprise Value to EBITDA Ratio|IGMS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp (OCEA) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|THRD: Business Value to Operating Income Before Depreciation
